The meningococcal vaccine MenAfriVac, which is made by the Indian generic drug company Serum Institute, is “dramatically better” at producing a protective effect among African children in three countries than “older so-called meningococcal polysaccaride vaccines, including Mencevax from GlaxoSmithKline,” according to a paper describing two studies published in the New England Journal of Medicine, Reuters reports.
Editorials and opinion pieces are responding to the GAVI Alliance pledging conference, which raised $4.3 billion for childhood vaccinations. The following is a summary of some of those pieces: Financial Times: Boosting vaccines: The editorial calls on GAVI to review its governance and do more to help reduce the price…
“Large donations from the U.K., Norway and the Bill & Melinda Gates Foundation helped a global vaccine charity raise $4.3 billion at a summit Monday, exceeding its targets and allowing it to carry out all its immunization plans through 2015,” the Wall Street Journal reports. The U.K. pledged $1.34 billion to the GAVI Alliance, the Gates Foundation promised $1 billion and Norway offered $677 million (Whalen, 6/14).
The New York Times reports on the success of a new meningococcal vaccine in West Africa, where very few cases of the disease have been detected in countries that use MenAfriVac, which costs 50 cents per dose.
A vaccine against the mosquito-borne infection dengue, the first to reach the final stage of clinical testing, “has seen ‘very promising’ results in Thailand, a specialist involved in the tests said on Friday,” Reuters reports (Petty/Mahlich, 6/10).
The GAVI Alliance pledging conference is “being seen as a litmus test of how well aid can survive in the age of austerity,” columnist Madeleine Bunting writes in a Guardian commentary, addressing how foreign aid is viewed as “soft power â€¦ [to] establish influence and spread values â€“ which is often more useful than diplomacy or defence in a post-cold war world.”
At a pledging conference for the GAVI Alliance in London on Monday, Bill Gates, co-chair of the Bill & Melinda Gates Foundation and Microsoft founder, announced his foundation will provide an additional $1 billion in funding for the organization over the next five years, while Australian Foreign Minister Kevin Rudd said his country will provide $210 million over the next three years, Reuters reports (Croft/Kelland, 6/13).
This fact sheet from the Kaiser Family Foundation examines the GAVI Alliance and the role the U.S. government plays in supporting the partnership. Created in 1999, GAVI began operations in January 2000 and by the end of 2010 had received over $5 billion in donor financing and disbursed over $2.8…
This Lancet series examines vaccine technology, “including the developments expected over the coming decade and what we can expect from translation of the latest vaccine science. Improving vaccine coverage and financing of both existing and newer vaccines together with how we communicate the benefits of vaccines and ensure public trust…
In a post on the Center for Global Development’s “Global Health Policy” blog, Amanda Glassman, CGD’s director of global health policy, discusses the U.S. pledge for the GAVI Alliance and outlines why providing $450 million over three years to GAVI “is both compassionate and cost-effective” (6/9).